(HealthDay News) — Multiple sclerosis patients may eventually benefit from a novel treatment that takes aim at the abnormal behavior of a specific type of immune cell, preliminary research suggests. The errant behavior of the cells in question — known as "B cells" — is viewed as key to the development of this chronic and [...]
(HealthDay News) — Black people with multiple sclerosis are more likely to have vitamin D deficiencies than blacks who don’t have the disease, a new study shows. The study, published in the May 24 issue of the journal Neurology, also said the deficiency is due primarily to differences in climate and geography. "MS is not [...]
HealthDay News — A new oral medication for the treatment of multiple sclerosis MS shows promise in slowing disease progression, limiting brain atrophy and reducing MS relapses, a recently completed two-year clinical trial demonstrates.The findings concern the experimental drug laquinimod, and stem from work with over 1,100 MS patients at 139 medical facilities in 24 [...]
I apologize in advance for posting this, as it can’t possibly be news to anyone with half a brain. (HealthDay News) — As the debate over medical marijuana use continues, a new study among multiple sclerosis patients — who often use the drug to relieve pain and muscle spasticity — adds to the argument that [...]
(HealthDay News) — U.S. scientists say they’ve coaxed human embryonic stem cells into generating cells that might someday be used to repair nerves damaged by multiple sclerosis. The researchers pushed the stem cells to grow into critical nervous system support cells called oligodendrocytes, according to a report released Thursday. Read on
(HealthDay News) — People with multiple sclerosis may have a lower overall risk of developing cancer, Swedish researchers report. The study, which tracked the medical records of more than 20,000 MS patients for 35 years, “found that they had some 10 percent decreased overall cancer risk compared with those without the disease,” said lead researcher [...]
